The immunomodulatory drugs used in SLE and lupus nephritis, Mycophenolate mofetil (MMF), exert their effects through inhibition of the PI3K/Akt/mTOR axis in T cells. The gene discussed is MTOR; the disease is systemic lupus erythematosus.